A double blind placebo Clinical Trial of Crystal Tomato® supplements and Crystal Tomato® Skin Clarity Cream was conducted in a tertiary dermatological institute in Singapore in 2014.
The trial involved 44 Melasma patients selected from those who had either been treated with or were still undergoing the industry gold standard “Triple Therapy” (Hydroquinone, Steroid and Retin-A) treatment for Melasma, but who had not or were not achieving the desired results.
These patients saw improvements by 25% after just 56 days of Crystal Tomato® Skin Clarity Cream. The result was further enhanced to over 50% improvement after the 84th day.
The results of the Crystal Tomato® and Crystal Tomato® Skin Clarity Cream Clinical Study were published in the peer-reviewed Journal of Pigmentary Disorders.